Faeth Therapeutics, Inc. (FTH)
19.39
+0.59
(+3.14%)
USD |
NASDAQ |
Oct 19, 16:00
19.39
0.00 (0.00%)
After-Hours: 16:22
Faeth Therapeutics Net Income (Quarterly) : -16.01M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.01M |
| March 31, 2026 | -170.24M |
| December 31, 2025 | -4.717M |
| September 30, 2025 | -4.569M |
| June 30, 2025 | -4.936M |
| March 31, 2025 | -6.864M |
| December 31, 2024 | -7.77M |
| September 30, 2024 | -7.253M |
| June 30, 2024 | -7.142M |
| March 31, 2024 | -7.992M |
| December 31, 2023 | -7.414M |
| September 30, 2023 | -7.124M |
| June 30, 2023 | -9.386M |
| March 31, 2023 | -10.18M |
| Date | Value |
|---|---|
| December 31, 2022 | -12.23M |
| September 30, 2022 | -13.42M |
| June 30, 2022 | -10.54M |
| March 31, 2022 | -12.40M |
| December 31, 2021 | -9.366M |
| September 30, 2021 | -9.685M |
| June 30, 2021 | -9.771M |
| March 31, 2021 | -7.972M |
| December 31, 2020 | -5.131M |
| September 30, 2020 | -5.367M |
| June 30, 2020 | -4.91M |
| March 31, 2020 | -4.692M |
| December 31, 2019 | -6.705M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Opus Genetics, Inc. | -8.098M |
| Nuvectis Pharma, Inc. | -7.02M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 16.01M |
| EPS Diluted (Quarterly) | -2.836 |
| Enterprise Value | 306.58M |
| Earnings Yield | -730.5% |
| Normalized Earnings Yield | -335.64 |